GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

zolucatetide   Click here for help

GtoPdb Ligand ID: 14191

Compound class: Peptide
Comment: In >10% of solid tumours aberrant Wnt/β-catenin signaling is a recognised driver of resistance to immunotherapy and is associated with poor prognosis. Zolucatetide (FOG-001; Parabilis Medicines) is a cyclic peptide inhibitor of the interaction between β-catenin and the T cell (transcription) factor TCF4 [1]. This action disrupts Wnt signaling, and is proposed for anti-tumour potential. The peptide is highly modified to optimise target engagement and pharmacokinetics.
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@H](C(=O)N)NC(=O)[C@@H]1CCC(=O)NCCCC[C@H]2C(=O)N[C@]3(CCN(C3)C(=O)OCCC/C=C/CCC[C@]4(CCC/C=C\C[C@]5(CCCN5C(=O)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)(C)C)C(=O)N4)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC6=CC=CC(=C6)C(=O)O)C(=O)NC(C)(C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC7=CC=CC=C7)C(=O)N2)C(=O)N[C@@H](CC8=CSC=C8)C(=O)N[C@@H](CC9=CSC%10=C9C=CC=C%10)C(=O)N1
Isomeric SMILES C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@]3(CCN(C3)C(=O)OCCC/C=C/CCC[C@]4(CCC/C=C\C[C@]5(CCCN5C(=O)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N4)CC(C)(C)C)CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NC(C(=O)N1)(C)C)CC6=CC(=CC=C6)C(=O)O)CC(=O)O)NC2=O)CC7=CSC=C7)CC8=CSC9=CC=CC=C98)C(=O)N[C@@H](C)C(=O)N)CC%10=CC=CC=C%10
InChI InChI=1S/C102H134N18O25S2/c1-59(81(103)127)105-83(129)69-35-36-78(122)104-43-24-20-33-68-89(135)118-101(95(142)113-71(51-64-37-47-146-56-64)85(131)111-73(86(132)108-69)52-66-57-147-77-34-19-18-32-67(66)77)42-45-119(58-101)97(144)145-46-25-14-10-9-11-21-38-100(39-22-12-13-23-40-102(41-27-44-120(102)61(3)121)96(143)115-75(54-80(125)126)88(134)112-76(91(137)117-100)55-98(4,5)6)94(141)114-74(53-79(123)124)87(133)110-72(50-63-30-26-31-65(48-63)92(138)139)90(136)116-99(7,8)93(140)106-60(2)82(128)109-70(84(130)107-68)49-62-28-16-15-17-29-62/h9-10,13,15-19,23,26,28-32,34,37,47-48,56-57,59-60,68-76H,11-12,14,20-22,24-25,27,33,35-36,38-46,49-55,58H2,1-8H3,(H2,103,127)(H,104,122)(H,105,129)(H,106,140)(H,107,130)(H,108,132)(H,109,128)(H,110,133)(H,111,131)(H,112,134)(H,113,142)(H,114,141)(H,115,143)(H,116,136)(H,117,137)(H,118,135)(H,123,124)(H,125,126)(H,138,139)/b10-9+,23-13-/t59-,60-,68-,69-,70-,71-,72-,73-,74-,75-,76-,100-,101-,102-/m0/s1
InChI Key QZAJMBQKMDKREN-XAAYEZHBSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Peptide Sequence Click here for help
No information available.
Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel